Citations for
1AKT1, ARHGEF3, CRTC2
XPLN is an endogenous inhibitor of mTORC2.
Khanna N, Fang Y, Yoon MS, Chen J.
Proc Natl Acad Sci U S A 110(40):15979-84. doi: 10.1073/pnas.1310434110. Epub 2013 Sep 16. 2013
2ARHGEF3, RHOA, RHOB
Structure of the Rho-specific guanine nucleotide-exchange factor Xpln.
Murayama K, Kato-Murayama M, Akasaka R, Terada T, Yokoyama S, Shirouzu M.
Acta Crystallogr Sect F Struct Biol Cryst Commun 68(Pt 12):1455-9. doi: 10.1107/S1744309112045265. Epub 2012 Nov 19. 2012
3ARHGEF3, RHOA
Silencing of RhoA nucleotide exchange factor, ARHGEF3, reveals its unexpected role in iron uptake.
Serbanovic-Canic J, Cvejic A, Soranzo N, Stemple DL, Ouwehand WH, Freson K.
Blood 118(18):4967-76. doi: 10.1182/blood-2011-02-337295. Epub 2011 Jun 28. 2011
4ARHGEF3
Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis.
Mullin BH, Prince RL, Dick IM, Hart DJ, Spector TD, Dudbridge F, Wilson SG.
Am J Hum Genet 82(6):1262-9. Epub 2008 May 22. 2008
5ARHGEF3, RHOA
XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
Arthur WT, Ellerbroek SM, Der CJ, Burridge K, Wennerberg K.
J Biol Chem 277(45):42964-72. Epub 2002 Sep 06. 2002
6ARHGEF3, ARHGEF4
Isolation of two novel human RhoGEFs, ARHGEF3 and ARHGEF4, in 3p13-21 and 2q22.
Thiesen S, Kubart S, Ropers HH, Nothwang HG.
Biochem Biophys Res Commun 273(1):364-9. 2000